Casaevades

Study provides new look at why rare cancer often evades treatments

Por um escritor misterioso
Last updated 14 abril 2025
Study provides new look at why rare cancer often evades treatments
Researchers at Boston Medical Center and Dana-Farber Cancer Institute have conducted one of the first-ever analyses of neuroendocrine tumors (NETs) at single-cell resolution, unlocking new insights into this rare and often hard-to-treat cancer. The findings represent a tremendous leap forward in understanding why these tumors are largely resistant to immunotherapy and provide key insights that could lead to future treatments.
Study provides new look at why rare cancer often evades treatments
CRISPR in Cancer Therapeutics: CAR T, NK, TCR and Beyond
Study provides new look at why rare cancer often evades treatments
The foundation and architecture of precision medicine in neurology and psychiatry: Trends in Neurosciences
Study provides new look at why rare cancer often evades treatments
Outsmart Your Cancer: Alternative by Pierce, Tanya Harter
Study provides new look at why rare cancer often evades treatments
Smart Nanomaterials in Cancer Theranostics: Challenges and Opportunities
Study provides new look at why rare cancer often evades treatments
Spatial omics and multiplexed imaging to explore cancer biology
Study provides new look at why rare cancer often evades treatments
Count Me In launches a rare cancer research project to engage leiomyosarcoma patients and families
Study provides new look at why rare cancer often evades treatments
Oncolytic viruses as emerging therapy against cancers including Oncovirus-induced cancers - ScienceDirect
Study provides new look at why rare cancer often evades treatments
Researchers Identify Potential Target for Rhabdomyosarcoma Recurrence Prevention
Study provides new look at why rare cancer often evades treatments
The cancer equation: Mathematically modelling the cure, The Independent
Study provides new look at why rare cancer often evades treatments
Hope for breast cancer patients, but with a cruel caveat — Harvard Gazette
Study provides new look at why rare cancer often evades treatments
Rewiring cell communication to treat melanoma
Study provides new look at why rare cancer often evades treatments
Precision therapy for RET-altered cancers with RET inhibitors: Trends in Cancer
Study provides new look at why rare cancer often evades treatments
How cancer doesn't happen - Part 2
Study provides new look at why rare cancer often evades treatments
Novel insights into HBV-hepatocellular carcinoma at single-cell sequencing
Study provides new look at why rare cancer often evades treatments
New technique could help make precision medicine more widely available
Recomendado para você
você pode gostar

© 2014-2025 trend-media.tv. All rights reserved.